Cargando…

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

Nasopharyngeal carcinoma (NPC) is a squamous carcinoma with apparent geographical and racial distribution, mostly prevalent in East and Southeast Asia, particularly concentrated in southern China. The epidemiological trend over the past decades has suggested a substantial reduction in the incidence...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Qian‐Ying, Zhao, Ge‐Xin, Li, Yan, Talakatta, Girish, Mai, Hai‐Qiang, Le, Quynh‐Thu, Young, Lawrence S., Zeng, Mu‐Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491203/ https://www.ncbi.nlm.nih.gov/pubmed/34766141 http://dx.doi.org/10.1002/mco2.32

Ejemplares similares

JUPITER‐02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps
por: Tan, Laura Ling Ying, et al.
Publicado: (2021)

Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
por: Wang, Na, et al.
Publicado: (2005)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

With or without reirradiation in advanced local recurrent nasopharyngeal carcinoma: a case–control study
por: Liu, Li-Ting, et al.
Publicado: (2016)

Prognostic Value of Plasma Epstein–Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era
por: Chen, Wen-Hui, et al.
Publicado: (2016)

Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine
por: Brandsma, Corry‐Anke, et al.
Publicado: (2019)

Discovery of recurrent structural variants in nasopharyngeal carcinoma
por: Valouev, Anton, et al.
Publicado: (2014)

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment
por: Gong, Lanqi, et al.
Publicado: (2021)

Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect
por: Siak, Pui Yan, et al.
Publicado: (2023)

Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
por: Ozen, Seza, et al.
Publicado: (2018)

ER-associated degradation in cystinosis pathogenesis and the prospects of precision medicine
por: Venkatarangan, Varsha, et al.
Publicado: (2023)

The putative tumor activator ARHGEF3 promotes nasopharyngeal carcinoma cell pathogenesis by inhibiting cellular apoptosis
por: Liu, Tian-Hao, et al.
Publicado: (2016)

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation
por: Jun, Michelle, et al.
Publicado: (2023)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
por: Gu, Ai-Di, et al.
Publicado: (2012)

Advances of Osteosarcoma Models for Drug Discovery and Precision Medicine
por: Tan, Linyun, et al.
Publicado: (2023)

Editorial: Radiomics Advances Precision Medicine
por: Gao, Bo, et al.
Publicado: (2022)

Epigenetic Regulation Mediated by Methylation in the Pathogenesis and Precision Medicine of Rheumatoid Arthritis
por: Guo, Shicheng, et al.
Publicado: (2020)

Identification of surrogate endpoints in patients with locoregionally advanced nasopharyngeal carcinoma receiving neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone
por: Chen, Yu-Pei, et al.
Publicado: (2015)

The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
por: Liu, Li-Ting, et al.
Publicado: (2018)

Precision medicine: In need of guidance and surveillance
por: Lin, Jian-Zhen, et al.
Publicado: (2017)

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
por: Liu, Li-Ting, et al.
Publicado: (2019)

Caesalpinia Crista Linn. Induces Protection against DNA and Membrane Damage
por: Kumar, R. Sunil, et al.
Publicado: (2017)

Emerging treatment options for nasopharyngeal carcinoma
por: Zhang, Lu, et al.
Publicado: (2013)

Clinical findings and imaging features of 67 nasopharyngeal carcinoma patients with postradiation nasopharyngeal necrosis
por: Chen, Ming-Yuan, et al.
Publicado: (2013)

Dystrophin Cardiomyopathies: Clinical Management, Molecular Pathogenesis and Evolution towards Precision Medicine
por: D’Amario, Domenico, et al.
Publicado: (2018)

Editorial: MINOCA: Pathogenesis, Diagnosis, Clinical Management and Evolution Towards Precision Medicine
por: D'Amario, Domenico, et al.
Publicado: (2022)

Rare Diseases: Implementation of Molecular Diagnosis, Pathogenesis Insights and Precision Medicine Treatment
por: Larizza, Lidia, et al.
Publicado: (2023)

Association of Treatment Advances With Survival Rates in Pediatric Patients With Nasopharyngeal Carcinoma in China, 1989-2020
por: Liang, Yu-Jing, et al.
Publicado: (2022)

Precision Medicine for Frontotemporal Dementia
por: Liu, Mu-N, et al.
Publicado: (2019)

Advances in Precision Medicine: Tailoring Individualized Therapies
por: Matchett, Kyle B., et al.
Publicado: (2017)

Advances in Text Mining and Visualization for Precision Medicine
por: Gonzalez-Hernandez, Graciela, et al.
Publicado: (2018)

Opportunities for Artificial Intelligence in Advancing Precision Medicine
por: Filipp, Fabian V.
Publicado: (2019)

Precision medicine advances in idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2023)

Ex vivo expansion of tumor-infiltrating lymphocytes from nasopharyngeal carcinoma patients for adoptive immunotherapy
por: He, Jia, et al.
Publicado: (2012)

Editorial: Machine Learning Advanced Dynamic Omics Data Analysis for Precision Medicine
por: Zeng, Tao, et al.
Publicado: (2020)

Knockdown of miR-214 Promotes Apoptosis and Inhibits Cell Proliferation in Nasopharyngeal Carcinoma
por: Zhang, Zi-Chen, et al.
Publicado: (2014)

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
por: Lee, Nancy Y., et al.
Publicado: (2023)

The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy
por: Guo, Shan-Shan, et al.
Publicado: (2015)

Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of (18)F-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence
por: Shen, Ting, et al.
Publicado: (2015)

Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma
por: Liu, Lizhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vhm2n1q6luaii6ir6la3bu6m68